Adrian Zai to Cost-Benefit Analysis
This is a "connection" page, showing publications Adrian Zai has written about Cost-Benefit Analysis.
Connection Strength
0.047
-
Wasfy JH, Strom JB, Waldo SW, O'Brien C, Wimmer NJ, Zai AH, Luttrell J, Spertus JA, Kennedy KF, Normand SL, Mauri L, Yeh RW. Clinical preventability of 30-day readmission after percutaneous coronary intervention. J Am Heart Assoc. 2014 Sep 26; 3(5):e001290.
Score: 0.026
-
Beauharnais CC, Larkin ME, Zai AH, Boykin EC, Luttrell J, Wexler DJ. Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trial. Clin Trials. 2012 Apr; 9(2):198-203.
Score: 0.021